Skip to main content

Spectroscopy Announces the Acquisition of Spectroscopy Europe and Spectroscopy World

Written by Customer Service on . Posted in Mergers And Acquisitions.

Ian Michael was the Editor and Publisher of Spectroscopy Europe and Spectroscopy World since 1975, where he wrote about the latest trends in analytical sciences.

Michael cared very deeply about the advertisers and readers of both publications, and always added a personal touch to his work.
Michael cared very deeply about the advertisers and readers of both publications, and always added a personal touch to his work.

CRANBURY, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) — MJH Life Sciences® and Spectroscopy® are thrilled to announce the acquisition of Spectroscopy Europe and Spectroscopy World, two leading digital magazines for experts in the analytical sciences. This acquisition will expand Spectroscopy’s global reach, growing its audience to more than 71,500 readers worldwide. The merger of the publications will expand Spectroscopy’s mission to provide valuable, practical and leading-edge information to the spectroscopy community.

“This exciting development is a key milestone as we forge ahead with our ambitious plans to grow within international markets,” said Michael J. Hennessy Jr., president, and CEO of MJH Life Sciences. “We are not just evolving; we are revolutionizing the landscape, and this is just one of many steps on our extraordinary journey into broader ex-US territories. The future is bright, and MJH Life Sciences is at the forefront, driving progress and pioneering change.”

Under the direction of Editor and Publisher Ian Michael, Spectroscopy Europe, and Spectroscopy World, have been writing about the latest trends in analytical sciences since 1975. Published six times a year, the digital magazines cover a wide range of techniques including imaging, atomic and molecular spectroscopy, handheld devices, and more. Michael, who died in April, was a well-respected expert, dedicating his career to advancing the field of spectroscopy.

Michael graduated from the University of St. Andrews with a Bachelor of Science in zoology. He served as an editor for John Wiley & Sons before founding IM Publications, the parent company of Spectroscopy Europe and Spectroscopy World. Katie Michael, his wife, said that he cared very deeply about the advertisers and readers of both publications, and always added a personal touch to his work.

Spectroscopy provides peer-reviewed articles, trusted advice from expert columnists, and the latest breaking developments to facilitate the advance of analytical spectroscopy and its use as an essential tool across a variety of applications and fields. Spectroscopy is indexed in the Web of Science, Journal Citation Reports, Scopus, EBSCOhost, and CAS Source Index (CASSI) Search Tool, and Digital Object Identifier (DOI) system. 

About MJH Life Sciences

MJH Life Sciences® (MJH) is the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, providing health care professionals with the information and resources they need to optimize patient outcomes. MJH combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and market research with the customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies. For more information, please visit https://www.mjhlifesciences.com/

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ed51ef67-9fe3-4c0e-85be-6d7252f00e22

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.